Abstract
Using gene targeting, we inserted a high-affinity variant of the reverse tetracycline controlled transactivator (rtTA) into the genomic Sox10 locus. This rtTA transgene faithfully recapitulated Sox10 expression in the emerging neural crest, several of its derivatives, and in oligodendrocytes. It was furthermore able to induce expression of a tetracycline inducible transgenic reporter gene in a doxycycline-dependent manner. Induction was fast, with substantial reporter gene expression visible 6 h after the onset of doxycycline treatment. Shut-off, in contrast, exhibited delayed kinetics, which probably correlated with doxycycline clearance rates. This mouse provides a useful tool for generating tetracycline-controlled gene expression in neural crest and oligodendrocytes.
Copyright 2004 Wiley-Liss, Inc.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cell Line
-
Crosses, Genetic
-
Female
-
Gene Expression Regulation, Developmental / drug effects*
-
Gene Targeting
-
High Mobility Group Proteins / genetics
-
High Mobility Group Proteins / physiology*
-
Humans
-
Integrases / genetics
-
Kinetics
-
Male
-
Metabolic Clearance Rate
-
Mice
-
Mice, Transgenic
-
Neoplasm Proteins / genetics
-
Neoplasm Proteins / physiology*
-
Neural Crest / metabolism*
-
Oligodendroglia / metabolism*
-
Protein Synthesis Inhibitors / pharmacology*
-
SOXE Transcription Factors
-
Tetracycline / pharmacology*
-
Trans-Activators / analysis
-
Trans-Activators / genetics*
-
Transcription Factors
-
Transgenes
-
beta-Galactosidase / metabolism
Substances
-
High Mobility Group Proteins
-
Neoplasm Proteins
-
Protein Synthesis Inhibitors
-
SOX10 protein, human
-
SOXE Transcription Factors
-
Sox10 protein, mouse
-
Trans-Activators
-
Transcription Factors
-
Cre recombinase
-
Integrases
-
beta-Galactosidase
-
Tetracycline